Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical vs Expectant Management for RPOC After Medical Abortion
NCT07534982Recruiting
- Sponsor
- Yael Yagur
- Start
- Jul 2024
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of misoprostol in retained products of conception (RPOC) (2 arms), sponsored by Yael Yagur. Primary endpoint: Resolution of Retained Products of Conception at 12 weeks. Started Jul 2024; status: recruiting.
02
Drugs
misoprostol
03
Conditions
retained products of conception (RPOC)
Beyond the preview
Go deeper on NCT07534982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07534982.